Search clinical trials for: Alectinib
Total 75 results
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerKorea, Republic of
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
University Medical Center GroningenRadboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaboratorsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Drug Monitoring | Anaplastic Lymphoma Kinase Gene Mutation | Anaplastic Lymphoma Kinase Gene TranslocationNetherlands, France
-
PfizerCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Hoffmann-La RocheCompletedHepatic ImpairmentCzechia, Slovakia
-
Gruppo Oncologico Italiano di Ricerca ClinicaRecruiting
-
Aarhus University HospitalRoche Pharma AGEnrolling by invitationLung Cancer | ALK Gene Mutation | Resistance, Disease | MutationDenmark
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungFrance
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Not yet recruitingNon-small Cell Lung CancerUnited States
-
Genentech, Inc.No longer available
-
Hoffmann-La RocheTerminatedDigestive System Diseases | Gastrointestinal Diseases | Melanoma | Sarcoma | Neoplasms | Respiratory Tract Diseases | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasms | Head and Neck Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms and other conditionsUnited States
-
TakedaActive, not recruitingALK+ Advanced NSCLCSpain, China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Italy, Romania, United States, Mexico, Croatia, Russian Federation, Argentina, Canada, Germany, France, Austria, Chile, Greece, Sweden
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingNeoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Neoplasms by Site | Renal Cell Carcinoma | Cancer | Solid Tumor | Anaplastic Large Cell Lymphoma | Neuroblastoma | Malignant Neoplasm | Haematological MalignancyUnited Kingdom
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingNSCLC Stage IV | ALK Gene Mutation | ALK Sensitizing MutationItaly
-
Instituto Nacional de Cancerologia de MexicoRecruitingALK Gene Mutation | Non-small Cell Lung Cancer Stage IIIBMexico
-
China Medical University HospitalRecruiting
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Canada
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedNon-small Cell Lung CancerChina
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Taiwan, Australia, France, Hong Kong, Italy, Portugal, Spain, United Kingdom, Brazil, Poland, Guatemala, Singapore, Thailand, Serbia, Ukraine, Bosnia and Herzegovina, Chile, China, Costa... and more
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Hoffmann-La RocheActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Hungary, Australia, Taiwan, China, Denmark, Italy, Spain, Turkey, Japan, France, Korea, Republic of, Germany, Poland, Thailand, Egypt, Russian Federation, Austria, Ukraine, United Kingdom, Romania, Kazakhstan, Bosnia... and more
-
Hoffmann-La RocheCompletedNon-Small-Cell Lung CarcinomaUnited States, Spain, France, Italy, Belgium, Korea, Republic of, Taiwan, United Kingdom, Luxembourg, Australia, Netherlands, Germany, Singapore, Denmark, Russian Federation, Sweden
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdTerminatedALK-positive Non-small Cell Lung CancerChina
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, United Kingdom, Australia, Denmark, France, Italy, Germany
-
Hoffmann-La RocheActive, not recruitingAnaplastic Lymphoma Kinase-positive Non-small Cell Lung CancerChina, Korea, Republic of, Thailand
-
Hoffmann-La RocheActive, not recruitingNSCLCBelgium, Australia, China, Croatia, Finland, Turkey, Italy, Israel, Serbia, Austria, Romania, Peru, Lithuania, Colombia, Portugal, Czechia, Cuba, Russian Federation, Bulgaria, Vietnam, Uruguay, United Arab Emirates, Argentina, Chile, Pa...
-
Joshua PalmerGenentech, Inc.RecruitingNSCLC | Lung Cancer | Brain MetastasesUnited States
-
Massachusetts General HospitalGenentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States
-
TakedaCompletedCarcinoma Non-small-cell Lung | Anaplastic Lymphoma Kinase-positiveUnited States
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, France, United Kingdom, Hong Kong
-
Hoffmann-La RocheRecruitingNeoplasmsItaly, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
-
Massachusetts General HospitalGenentech, Inc.UnknownNon-Small Cell Lung Cancer (NSCLC)United States
-
GlaxoSmithKlineCompleted
-
AbbVie (prior sponsor, Abbott)CompletedDiabetic Nephropathy | Chronic Kidney DiseaseJapan
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Belgium, Canada, Australia, Brazil, China, Japan, Taiwan, Israel, France, Singapore, Germany, Spain, Thailand, Italy, Sweden, Turkey, Colombia, Costa Rica, Hong Kong, Poland, Chile, United Kingdom, New... and more
-
Hoffmann-La RocheCompleted
-
David LeafNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedAcute Kidney Injury | Critically IllUnited States
-
Centre Leon BerardRecruiting
-
Hospital Israelita Albert EinsteinMinistry of Health, BrazilCompleted
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Hoffmann-La RocheCompletedHealthy VolunteerUnited States
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
The University of Hong Kong-Shenzhen HospitalTianjin Happy Life Technology Co., Ltd.Not yet recruitingFeasibility | Safety | Targeted Molecular Therapy | Effectiveness
-
Genentech, Inc.Blueprint Medicines CorporationRecruitingNon-small Cell Lung CancerUnited States
-
German Cancer Research CenterRecruiting